Chronic wasting disease poses three critical challenges to disease management that public health and wildlife authorities must address immediately. First, infectious prions persist in asymptomatic animals that show no clinical signs, making traditional symptom-based detection unreliable. Second, laboratory evidence confirms the disease’s capacity to cross species barriers, elevating zoonotic risk beyond current risk assessments.
Third, despite zero confirmed human infections globally, the disease’s evolutionary potential demands precautionary surveillance infrastructure. Current wildlife management and veterinary screening protocols require urgent refinement to detect and contain silent carriers before they facilitate further transmission.
Practical implications are clear: agencies must transition from reactive, symptom-focused surveillance to proactive screening that captures asymptomatic carriers. Enhanced tissue sampling protocols, molecular diagnostics, and cross-border coordination are no longer optional—they are essential safeguards for wildlife populations and public health security.
Was this article helpful?
